Summary
Urinary urgency, frequency, incontinence, and recurrent UTIs are common but often overlooked symptoms of menopause. In this blog post, Dr. Couri reviews current research supporting topical vaginal estrogen as a first-line treatment for menopause-related urinary symptoms and explains how personalized care at the Couri Center in Peoria, IL may help.
Are you tired of dealing with urinary urgency, urinary frequency, or urinary incontinence? If so, keep reading.
For decades, we’ve known that vaginal estrogen is the gold-standard treatment for the dryness, burning, painful intercourse, and vulvovaginal discomfort of genitourinary syndrome of menopause (GSM). But many women are surprised to learn that vaginal estrogen does far more than simply restore moisture—it can significantly improve urinary symptoms as well.
A brand-new systematic review and meta-analysis (covering studies from inception through 2024) has now given us the strongest evidence to date that topical vaginal estrogen therapy improves all lower urinary tract symptoms (LUTS) associated with menopause.
This is something I see every day in practice—and now we have high-quality data to reinforce what our patients already tell us: vaginal estrogen works.
Why Menopause Affects the Urinary Tract
Estrogen receptors aren’t just in the vagina—they are also abundant in the urethra, bladder, pelvic floor muscles, and vulvar tissues. When estrogen levels decline, these structures thin, weaken, and become more vulnerable to irritation and infection.
This hormonal shift leads to symptoms such as:
- Urinary urgency
- Urinary frequency
- Nocturia (waking at night to urinate)
- Stress or urge incontinence – leaking urine with coughing, sneezing, laughing, or exercising or the inability to hold your urine when the bladder is full
- Recurrent urinary tract infections
Left untreated, these symptoms can have a profound effect on daily life, emotional wellbeing, intimacy, and sleep.
What the New Meta-Analysis Found
Researchers reviewed 17 studies involving 2,111 postmenopausal women using topical vaginal estrogen in various formulations—estradiol, estriol, or conjugated estrogens.
Across the board, treatment resulted in meaningful improvement in every urinary symptom evaluated.
Key Findings
Compared after vs. before treatment:
- Recurrent UTIs decreased by 86%
- Stress urinary incontinence decreased by 88%
- Urge incontinence decreased by 78%
- Urgency decreased by 89%
- Frequency decreased by 78%
- Nocturia decreased by 76%
In addition, vaginal pH improved significantly, becoming more acidic—which means a healthier environment that supports beneficial lactobacilli and helps prevent recurrent vaginal and bladder infections (UTIs).
These improvements were seen across multiple estrogen types and delivery methods, and importantly, systemic absorption remained minimal, consistently within the postmenopausal range. Therefore, vaginal estrogen is safe for women who have breast cancer or who are breast cancer survivors.
What This Means for Women
This comprehensive study reinforces what major guidelines (NAMS, EAU, NICE) already recommend:
Topical vaginal estrogen should be a first-line therapy for urinary symptoms related to menopause.
For most women, vaginal estrogen is used daily for approximately 2 weeks, then reduced to a maintenance schedule of 2–3 times per week. Symptoms often return if treatment is stopped, so continued use is key. I recommend using vaginal estrogen at bedtime, but any time of the day is fine.
My Takeaway as a Gynecologist
Urinary symptoms of menopause are incredibly common—but they are also incredibly undertreated. Too many women are told to “drink more water,” “limit water intake,” “do more Kegels,” or “just live with it.” They deserve better.
This new meta-analysis confirms what we have long emphasized at the Couri Center:
Restoring healthy estrogen levels to the vulvovaginal and lower urinary tract tissues is one of the most effective, safest, and most life-changing treatments we can offer menopausal women.
When we treat GSM comprehensively—with vaginal estrogen, pelvic floor support/pelvic physical therapy or Emsella when needed, and lifestyle optimization—women regain comfort, confidence, and control.
In short: You do not have to live with urinary symptoms. Help is available—and it works.
If you’d like to learn more about whether vaginal estrogen therapy is right for you, our team is here to support you. Menopause is a journey, and you deserve to feel healthy, vibrant, and empowered through every phase of it.
New patients are always welcome.
Schedule online BELOW or call the Couri Center at 309 692-6838 to discuss personalized menopause care.
To Your Health,
Dr. Michele Couri
About Dr. Michele Couri
Dr. Michele Couri is a board-certified OB/GYN and Medical Director of the Couri Center for Gynecology and Integrative Women’s Health in Peoria, Illinois. She specializes in integrative women’s health, menopause and perimenopause care, and hormone therapy, combining evidence-based medicine with personalized, patient-centered care.
CONTACT US-ARTICLE
Sources:
Porcari, I., Uccella, S., Casprini, C., Bosco, M., Zorzato, P. C., & Garzon, S. (2025). Vulvovaginal estrogen therapy for urinary symptoms in postmenopausal women: a review and meta-analysis. Climacteric, 1–10. https://doi.org/10.1080/13697137.2025.2517138
Disclaimer:
This article is for educational purposes only and is not intended to provide medical advice. Individual treatment decisions should always be made in consultation with your healthcare provider. If you have questions about your health or would like personalized care, please consult your provider or schedule an appointment at the Couri Center.